
Lockheed Martin [LMT] licensed the Dermoskeleton bionic augmentation technology from Canada’s B-Temia, Inc. for use in its exoskeleton research, Lockheed Martin said Tuesday.This licensing agreement will permit Lockheed Martin to use the technology in the company’s military, industrial, commercial, and first-responder product applications.The Dermoskeleton is the basis for computer-controlled devices that can increase load-carrying capacity and mobility by counteracting overstress on a person’s lower back and legs.Lockheed Martin is conducting exoskeleton research to help soldiers carry heavy equipment over long…